Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170011/S056

Impella RP System; Impella RP with SmartAssist System; Impella RP Flex with SmartAssist System;

Abiomed, Inc. · Decision date Aug 1, 2025

FDA DECISIONP170011/S056

What did the FDA approve?

FDA records P170011/S056 as a supplement to PMA P170011, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 1, 2025.

FDA approval order statement

approval for modifying the Impella labeling to reflect the findings of the Impella Sodium Bicarbonate Post-Approval Study
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Aug 1, 2025
FDA change category
Labeling Change - PAS

FDA source record

Regulatory record facts

Identifier
P170011/S056
Regulatory pathway
PMA supplement
Applicant
Abiomed, Inc.
Product code
PYX
Decision code
APPR
Decision date
Aug 1, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Temporary non-roller type right heart support blood pump.

Applicant
Abiomed, Inc.
Product code
PYX
FDA device class
3

For the original device and its historical approval scope, see PMA P170011. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170011 · Original PMA

    Impella RP System

  2. P170011/S056 received

    Application receipt date recorded by FDA.

  3. P170011/S059 · Related supplement

    Impella RP, Impella RP with SmartAssist, and Impella RP Flex with SmartAssist

  4. P170011/S056 · FDA decision

    Normal 180 Day Track No User Fee

  5. P170011/S060 · Related supplement

    Impella RP, Impella RP with SmartAssist, Impella RP Flex with SmartAssist

  6. P170011/S062 · Related supplement

    Impella CP with SmartAssist; Impella 5.5 with SmartAssist

  7. P170011/S061 · Related supplement

    Impella RP System, Impella RP with Smart Assist System, Impella RP Flex System

  8. P170011/S064 · Related supplement

    Impella RP Flex with SmartAssist

Timeline entries are records held by MedtechLedger for P170011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170011

Product / regulatory recordCompanyPathwayDecision dateSource
Abiomed, Inc.PMA approvalSep 20, 2017FDA
Abiomed, Inc.PMA supplementJul 25, 2025FDA
Purge CassetteP170011/S058
Abiomed, Inc.PMA supplementSep 15, 2025FDA
Abiomed, Inc.PMA supplementSep 19, 2025FDA
Abiomed, Inc.PMA supplementDec 19, 2025FDA
Abiomed, Inc.PMA supplementFeb 6, 2026FDA
Impella RP SystemP170011/S063
Abiomed, Inc.PMA supplementApr 1, 2026FDA
Abiomed, Inc.PMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abiomed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
22 Cherry Hill Dr., Danvers, MA, 01923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records